Company Number: 14760845

Analysis Date: 2025-07-19 12:06 UTC

Financial Health Assessment for Bear Cross Pharma Ltd as of 31 March 2024

---

1. Financial Health Score: C

Explanation:
Bear Cross Pharma Ltd is a newly incorporated private limited company operating in the specialised dispensing chemist sector. The company shows a positive net asset position and shareholders’ funds, but the financial structure presents some warning signs, particularly with significant long-term creditors. The company is in its infancy, so the current financial data reflects early-stage business development rather than mature operational performance. The overall score "C" reflects a cautious but stable start with areas needing close monitoring and proactive management.

---

2. Key Vital Signs

Metric	Figure (£)	Interpretation
Current Assets	13,657	Modest level of short-term assets, including cash and debtors, indicating liquidity available.
Cash on Hand	7,347	Cash balance is reasonable for operational needs but limited in scale.
Debtors	6,310	Amount due from customers; a moderate figure for a start-up, no evident liquidity issues.
Current Liabilities	4,000	Short-term obligations are relatively low, suggesting manageable immediate payment needs.
Net Current Assets (Working Capital)	17,657	Positive working capital indicates a "healthy cash flow" situation for day-to-day operations.
Creditors due after 1 year (Long-term liabilities)	107,577	Significant long-term debt, a "symptom of financial stress" that could impact future cash flow.
Net Assets	125,234	Strong net asset position reflecting equity investment exceeding liabilities.
Shareholders’ Funds	128,475	Positive equity base, indicating owners’ investment and retained funds support the business.
Profit and Loss Account	(111,358)	Accumulated losses suggest early operational costs and investment exceed initial income.

---

3. Diagnosis

Bear Cross Pharma Ltd is in the early stages of its financial lifecycle, with a foundation supported by shareholders’ equity. The positive net current assets reveal the company can cover its short-term liabilities, which is a crucial "vital sign" of financial health. However, the presence of substantial long-term creditors (£107,577) indicates reliance on external funding or loans that will require future repayment. This represents a potential risk factor, akin to a "chronic condition" that can strain the company’s financial resilience if not carefully managed.

The accumulated losses in the profit and loss reserve are typical for a start-up investing in growth, product development, or inventory but underscore the need for revenue growth and improved profitability. The absence of employees suggests operations might be minimal or outsourced at this stage.

Given the company’s sector (dispensing chemist in specialised stores), cash flow management is critical due to inventory and regulatory requirements. The current figures suggest the company is maintaining "healthy cash flow," but must be cautious about the debt burden and operating expenses.

---

4. Recommendations

• Debt Management: Develop a clear plan to manage and gradually reduce the long-term creditors to avoid liquidity pressure. Consider refinancing options or negotiating terms to ease cash flow impact.
• Revenue Growth: Focus on increasing sales and establishing a steady income stream to move the profit and loss account into positive territory. Explore marketing to build customer base and specialised service offerings.
• Cash Flow Monitoring: Maintain rigorous short-term cash flow forecasting to ensure liquidity remains sufficient to cover operational expenses and creditor payments.
• Cost Control: Keep operating costs low during this early stage to preserve capital. Avoid unnecessary expenses until revenue generation stabilises.
• Financial Reporting: Continue filing timely and accurate accounts and returns to maintain compliance and build credibility with stakeholders.
• Strategic Planning: Prepare for scaling operations by planning workforce needs and investment in inventory and equipment aligned with anticipated growth.
• Seek Expert Advice: Regular engagement with financial and industry advisors to monitor financial health and adapt business strategy as the market environment evolves.

---